跳至主要内容
临床试验/ISRCTN91372291
ISRCTN91372291已完成不适用

Post-market clinical follow-up study evaluating the efficacy and safety of LifeVest in real-life settings in France

ZO0 个研究点目标入组 550 人开始时间: 2016年1月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Patients receiving a LifeVest prescription in clinical routine. The following indications are authority approved:
  • 1. Implantable cardiac defibrillator (ICD) removal due to cardiac device infections
  • 2. A bridge to heart transplantation
  • 3. In the early post-MI period with left ventricular (LV) dysfunction (LVEF <30%)
  • 4. Recent coronary revascularization with LV dysfunction (LVEF < 30%)

排除标准

  • Patients who are physically or mentally unable to handle and use the WCD device appropriately, as judged by their responsible physician.

研究者

发起方
ZO

相似试验